Vertex Pharmaceuticals, Inc. (vrtx) Q2 2024 Earnings Call Transcript
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Reshma Kewalramani - Chief Executive Officer, President Stuart Arbuckle - Chief Operating Officer Charlie Wagner - Chief Financial Officer. Susie Lisa - Senior Vice President, Investor Relations Salveen Richter - Goldman Sachs David Risinger - Leerink Partners Jessica Fye - J.P. Morgan Evan Seigerman - BMO Capital Markets Chris Raymond - Piper Sandler Terence Flynn - Morgan Stanley Mohit Bansal - Wells Fargo Liisa Bayko - Evercore ISI Michael Yee - Jeffries Good day!
Agios Pharmaceuticals, Inc. (agio) Q2 2024 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Results Conference Call August 1, 2024 8:00 AM ET Chris Taylor - Vice President, Investor Relations and Corporate Communications Brian Goff - Chief Executive Officer Sarah Gheuens - Chief Medical Officer and Head, R&D Tsveta Milanova - Chief Commercial Officer Cecilia Jones - Chief Financial Officer Eric Schmidt - Cantor Christopher Raymond - Piper Sandler Gregory Renza - RBC Capital Markets Divya Rao - TD Cowen Tess Romero - JP Morgan Alec Stranahan - Bank of America Good morning, and welcome to Agios' Second Quarter 2024 Conference Call. [Operator Instructions].
Healthcare & Life Sciences Private Equity Deal Tracker: Hamilton Lane Acquires Stake In Avista-backed Cosette Pharmaceuticals | Mcguirewoods Llp
Hamilton Lane has acquired a significant equity interest in Cosette Pharmaceuticals from Avista Capital Partners and its co-investors, according to a news release....By: McGuireWoods LLP.
Xenon Pharmaceuticals Inc. (xene) Q1 2024 Earnings Call Transcript
Chad Fugere - Vice President, Investor Relations Ian Mortimer - President and CEO Dr. Chris Kenney - Chief Medical Officer Dr. Chris Von Seggern - Chief Commercial Officer Sherry Aulin - Chief Financial Officer Paul Matteis - Stifel Leo Timashev - RBC Capital Markets Jason Gerberry - Bank of America Luke Hermann - Baird Tess Romero - JPMorgan Khalil Fenina - Goldman Sachs Alex Nackenoff - Raymond James Basma Radwan - Leerink Andrew Tsai - Jefferies Peyton Bohnsack - TD Cowen Tim Lugo - William Blair Mohit Bansal - Wells Fargo David Huang - Citigroup Thank you for standing by.
Oric Pharmaceuticals Announces $125M Private Placement Financing -january 22, 2024 At 08:31 Am Est | Marketscreener
(marketscreener.com) Funding from new and existing investors including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, New Enterprise Associates , and Nextech Pro forma cash and investments expected to fund current operating plan into late 2026 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 22, 2024 -- ORIC...https://www.marketscreener.com/quote/stock/ORIC-PHARMACEUTICALS-INC-105997964/news/ORIC-Pharmaceuticals-Announces-125-Million-Private-Placement-Financing-45784774/?utm_medium=RSS&utm_content=20240122.
Verrica Pharmaceuticals Inc. (vrca) Q3 2023 Earnings Call Transcript
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Good morning, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals Third Quarter 2023 Corporate Update and Earnings Conference Call. As a reminder, this conference is being recorded. I will now turn the call over to our host, Kevin Gardner of LifeSci Advisors. You may begin your conference. Thank you, operator. Hello, everyone, and welcome to Verrica Pharmaceuticals Third Quarter 2023 Corporate Update and Earnings Conference Call.
Torrent Pharmaceutical In Talks With Apollo To Borrow Up To $1B For Cipla Bid
India's Torrent Pharmaceutical is in talks with Apollo Global Management for a loan of up to $1bn to fund a bid for Cipla.
Marinus Pharmaceuticals, Inc. (mrns) Q2 2023 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2023 Earnings Conference Call August 10, 2023 8:30 AM ET Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. And now it is my pleasure to introduce you to your host, Sonya Weigle, Senior Vice President Investor Relations, Human Resources, and Corporate Affairs. You may now begin Ms. Weigle. Thank you and good morning.
Tagworks Pharmaceuticals Announces $65M In Series A Financing To Advance Click-to-release Therapeutics
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) and immunomodulators, as well as...